OPKO Health, Inc. (NAS: OPK) Stock Analysis & Fundamentals | ScreenerHero

Create free account

OPKOPKO Health, Inc.

NAS · US · Healthcare · Diagnostics & Research · opko.com

1.190USD-0.83%Mkt Cap: 898.56M $P/E: —1d ago

OPKO Health, Inc. operates as a healthcare company, in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company operates in two segments, Pharmaceutical and Diagnostics. The Pharmaceutic…

Industry Peers

Diagnostics & Research

Thermo Fisher Scientific Inc.

$201.86BUSDP/E 29.8

Danaher Corporation

$145.10BUSDP/E 39.7

$45.85BUSDP/E 44.2

IDEXX Laboratories, Inc.

$45.44BUSDP/E 42.4

Agilent Technologies, Inc.

$38.44BUSDP/E 27.3

Waters Corporation

$37.13BUSDP/E 48.1

IQVIA Holdings Inc.

$35.13BUSDP/E 26.2

$28.78BUSDP/E 34.6

Mettler-Toledo International Inc.

$26.98BUSDP/E 31.4

Quest Diagnostics Incorporated

$23.18BUSDP/E 23.1

Labcorp Holdings Inc.

$23.12BUSDP/E 25.0

Guardant Health, Inc.

Medpace Holdings, Inc.

$15.36BUSDP/E 33.9

Eurofins Scientific SE

$13.06BUSDP/E 27.3

$12.46BUSDP/E 53.7

Charles River Laboratories International, Inc.

bioMérieux S.A.

$9.26BUSDP/E 21.6

BillionToOne, Inc.

$5.90BUSDP/E 237.4

Twist Bioscience Corporation

Sotera Health Company

$5.21BUSDP/E 44.6

$4.73BUSDP/E 54.8

DiaSorin S.p.A.

$3.75BUSDP/E 26.5

Adaptive Biotechnologies Corporation

NeoGenomics, Inc.

GeneDx Holdings Corp.

Vimian Group AB (publ)

$1.64BUSDP/E 41.7

Personalis, Inc.

Diagnostyka S.A.

$1.48BUSDP/E 22.4

Clínica Baviera, S.A.

$1.02BUSDP/E 21.4

Castle Biosciences, Inc.

$616.40MUSDP/E 40.2

Myriad Genetics, Inc.

Fulgent Genetics, Inc.

$293.12MUSDP/E 2.9

Spectral Medical Inc.

Insight Molecular Diagnostics Inc.

Scope Fluidics S.A.

Eurofins-Cerep SA

$89.37MUSDP/E 17.2

Pangaea Oncology, S.A.

Abingdon Health Plc

Immunovia AB (publ)

Proteome Sciences plc

ENDRA Life Sciences Inc.

Oxford BioDynamics Plc

Avricore Health Inc.

bioAffinity Technologies, Inc.

Leveljump Healthcare Corp.

Prostatype Genomics AB (publ)

Telo Genomics Corp.

ProPhase Labs, Inc.

Many Bright Ideas Technologies Inc.

$314.2KUSDP/E Infinity

T2 Biosystems, Inc.

Indicators:|

Key Statistics

Company

Market Cap898.56M $

Enterprise Value963.62M $

Revenue (TTM)581.12M $

Gross Profit205.94M $

Net Income (TTM)-225.68M $

Revenue/Share0.7520 USD

Last Price1.190 USD

Fiscal Year EndDec 2025

MR QuarterMar 2026

Employees2.3K

CountryUS

SectorHealthcare

IndustryDiagnostics & Research

ISINUS68375N1037

Valuation

P/E (Trailing)—

P/E (Forward)-3.72

PEG93.65

EV/EBITDA-8.57

EV/Revenue1.66

P/S1.55

P/B0.75

EPS (TTM)-0.27

EPS (Forward)-0.32

52W Range

0.980034% of range1.605

52W High1.605 USD

52W Low0.9800 USD

Profitability

Gross Margin33.93%

Oper. Margin-41.08%

EBITDA Margin-19.36%

Profit Margin-37.19%

ROE-17.80%

ROA-11.68%

Growth

Revenue Growth-17.20%

Earnings Growth—

Cash Flow & Leverage

Operating CF-178.54M $

CapEx (TTM)12.28M $

FCF Margin-6.21%

FCF Yield-4.02%

Net Debt65.06M $

Net Debt/EBITDA-0.58

Balance Sheet

Debt/Equity0.31

Current Ratio3.61

Quick Ratio2.83

Book Value/Sh1.595 USD

Cash/Share0.4390 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 USD

Div. Yield—

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Analyst Consensus

Rating—

Target (Mean)4.375 USD

Upside (mean)+267.6%

Target Range3.000 USD – 8.500 USD

$3.000+267.6% to mean$8.500

# Analysts4

Ownership

Shares Out.755.09M

Float332.82M

Insiders49.95%

Institutions27.02%

Short Interest

Short Ratio10.2d

Short % Float7.70%

Short % Out.4.32%

Shares Short32.59M

Short (prev mo.)33.04M

Technical

SMA 501.338 (-11.1%)

SMA 2001.308 (-9.0%)

Beta1.48

S&P 52W Chg20.25%

Avg Vol (30d)2.92M

Avg Vol (10d)2.61M

Technical Indicators

RSI (14)27.0

MACD-0.0364

MACD Signal0.0070

MACD Hist.-0.0434

BB Upper1.647 USD

BB Middle1.413 USD

BB Lower1.180 USD

BB Width32.98%

ATR (14)0.0654 USD

Vol Ratio (20d)1.21x